Non-targeted effects of ionising radiation-Implications for low dose risk

Mutation Research - Reviews in Mutation Research

Volumn 752, Issue 2, 2013, Pages 84-98

  Kadhim, Munira ^a   Salomaa, Sisko ^b   Wright, Eric ^c   Hildebrandt, Guido ^d   Belyakov, Oleg V ^e   Prise, Kevin M ^f   Little, Mark P ^g  

^a OXFORD BROOKES UNIVERSITY   (United Kingdom)

^b STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^f QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^g NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Health risk; Ionising radiation; Low dose; Non cancer disease; Non targeted effects

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CYCLOOXYGENASE 2; INTERLEUKIN 33; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR;

APOPTOSIS; BYSTANDER EFFECT; CANCER RADIOTHERAPY; CANCER SUSCEPTIBILITY; CATARACT; CELL COMMUNICATION; CELL TRANSFORMATION; CHROMOSOMAL INSTABILITY; CLONAL VARIATION; DNA CROSS LINKING; DNA DAMAGE; DNA REPLICATION; DOSE RESPONSE; DOUBLE STRANDED DNA BREAK; EPIGENETICS; GAP JUNCTION; GENE EXPRESSION; GENE MUTATION; GENOMIC INSTABILITY; GENOTYPE; HOMOLOGOUS RECOMBINATION; HUMAN; IONIZING RADIATION; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; NEOPLASM; NONHUMAN; NONTARGETED EFFECT; PRIORITY JOURNAL; RADIATION DOSE; RADIATION ENERGY; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION PROTECTION; RADIATION RESPONSE; RADIOBIOLOGY; RECOMBINATION REPAIR; REVIEW; SIGNAL TRANSDUCTION; SISTER CHROMATID EXCHANGE; ADAPTATION; ANIMAL; CELL FUNCTION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BYSTANDER EFFECT; CELL PHYSIOLOGICAL PHENOMENA; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENOMIC INSTABILITY; HUMANS; RADIATION, IONIZING;

EID: 84876784653     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2012.12.001     Document Type: Review

References (229)

1. Prise K.M., O'Sullivan J.M. Radiation-induced bystander signalling in cancer therapy. Nat. Rev. Cancer 2009, 9:351-360.
2. Sjostedt S., Bezak E. Non-targeted effects of ionising radiation and radiotherapy. Australas. Phys. Eng Sci. Med. 2010, 33:219-231.
3. Hei T.K., Zhou H., Chai Y., Ponnaiya B., Ivanov V.N. Radiation induced non-targeted response: mechanism and potential clinical implications. Curr. Mol. Pharmacol. 2011, 4:96-105.
4. Salomaa S.I., Wright E.G., Hildebrandt G., Kadhim M.A., Little M.P., Prise K.M., Belyakov O.V. Editorial-non-DNA targeted effects. Mutat. Res. 2010, 687:1-2.
5. Stevens L.G. Injurious effects on the skin. BMJ 1896, 1(998).
6. Gilchrist T.C. A case of dermatitis due to the X-rays. Bull. Johns Hopkins Hosp. 1897, 8(71):17-22.
7. Frieben A. Demonstration eines Cancroids des rechten Handrückens, das sich nach langdauernder Einwirkung von Röntgenstrahlen bei einem 33 jährigen Mann entwickelt hatte. Fortschr. Röntgenstr. 1902, 6(106).
8. International Commission on Radiological Protection, ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs - threshold doses for tissue reactions in a radiation protection context, ICRP publication 118, Ann. ICRP 41 (2012) 1-322.
9. Edwards A.A., Lloyd D.C. Risks from ionising radiation: deterministic effects. J. Radiol. Prot. 1998, 18:175-183.
10. Harris H. A long view of fashions in cancer research. Bioessays 2005, 27:833-838.
11. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), Sources and effects of ionizing radiation, UNSCEAR 1993 report to the General Assembly, with scientific annexes, E.94.IX.2, New York, United Nations, 1993, pp. 1-922.
12. Lea D.E. Actions of Radiations on Living Cells 1946, Cambridge University Press, Cambridge.
13. Preston D.L., Ron E., Tokuoka S., Funamoto S., Nishi N., Soda M., Mabuchi K., Kodama K. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat. Res. 2007, 168:1-64.
14. Ozasa K., Shimizu Y., Suyama A., Kasagi F., Soda M., Grant E.J., Sakata R., Sugiyama H., Kodama K. Studies of the mortality of atomic bomb survivors, report 14, 1950-2003: an overview of cancer and noncancer diseases. Radiat. Res. 2012, 177:229-243.
15. Hall E.J., Giaccia A. Radiobiology for the Radiologist 2012, Lippincott, Williams & Wilkins, Philadelphia, PA, pp. 1-576. 7th edition.
16. Little M.P., Wakeford R., Tawn E.J., Bouffler S.D., Berrington de G.A. Risks associated with low doses and low dose rates of ionizing radiation: why linearity may be (almost) the best we can do. Radiology 2009, 251:6-12.
17. Tubiana M., Feinendegen L.E., Yang C., Kaminski J.M. The linear no-threshold relationship is inconsistent with radiation biologic and experimental data. Radiology 2009, 251:13-22.
18. Puck T.T., Marcus P.I. Action of X-rays on mammalian cells. J. Exp. Med. 1956, 103:653-666.
19. Gorgojo L., Little J.B. Expression of lethal mutations in progeny of irradiated mammalian cells. Int. J. Radiat. Biol. 1989, 55:619-630.
20. Emerit I. Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis. Free Radic. Biol. Med. 1994, 16:99-109.
21. Kaminski J.M., Shinohara E., Summers J.B., Niermann K.J., Morimoto A., Brousal J. The controversial abscopal effect. Cancer Treat. Rev. 2005, 31:159-172.
22. Little M.P., Tawn E.J., Tzoulaki I., Wakeford R., Hildebrandt G., Paris F., Tapio S., Elliott P. A systematic review of epidemiological associations between low and moderate doses of ionizing radiation and late cardiovascular effects, and their possible mechanisms. Radiat. Res. 2008, 169:99-109.
23. Little M.P., Tawn E.J., Tzoulaki I., Wakeford R., Hildebrandt G., Paris F., Tapio S., Elliott P. Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms. Radiat. Environ. Biophys. 2010, 49:139-153.
24. Little M.P., Azizova T.V., Bazyka D., Bouffler S.D., Cardis E., Chekin S., Chumak V.V., Cucinotta F.A., de V.F., Hall P., Harrison J.D., Hildebrandt G., Ivanov V., Kashcheev V.V., Klymenko S.V., Kreuzer M., Laurent O., Ozasa K., Schneider T., Tapio S., Taylor A.M., Tzoulaki I., Vandoolaeghe W.L., Wakeford R., Zablotska L.B., Zhang W., Lipshultz S.E. Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks. Environ. Health Perspect. 2012, 120:1503-1511.
25. Worgul B.V., Kundiyev Y.I., Sergiyenko N.M., Chumak V.V., Vitte P.M., Medvedovsky C., Bakhanova E.V., Junk A.K., Kyrychenko O.Y., Musijachenko N.V., Shylo S.A., Vitte O.P., Xu S., Xue X., Shore R.E. Cataracts among Chernobyl clean-up workers: implications regarding permissible eye exposures. Radiat. Res. 2007, 167:233-243.
26. Neriishi K., Nakashima E., Minamoto A., Fujiwara S., Akahoshi M., Mishima H.K., Kitaoka T., Shore R.E. Postoperative cataract cases among atomic bomb survivors: radiation dose response and threshold. Radiat. Res. 2007, 168:404-408.
27. Ainsbury E.A., Bouffler S.D., Dorr W., Graw J., Muirhead C.R., Edwards A.A., Cooper J. Radiation cataractogenesis: a review of recent studies. Radiat. Res. 2009, 172:1-9.
28. Lorimore S.A., Kadhim M.A., Pocock D.A., Papworth D., Stevens D.L., Goodhead D.T., Wright E.G. Chromosomal instability in the descendants of unirradiated surviving cells after alpha-particle irradiation. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:5730-5733.
29. Dubrova Y.E., Plumb M., Gutierrez B., Boulton E., Jeffreys A.J. Transgenerational mutation by radiation. Nature 2000, 405:37.
30. Morgan W.F. Non-targeted and delayed effects of exposure to ionizing radiation: I. Radiation-induced genomic instability and bystander effects in vitro. Radiat. Res. 2003, 159:567-580.
31. Morgan W.F. Non-targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat. Res. 2003, 159:581-596.
32. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), UNSCEAR 2006 Report, Annex C, Non-Targeted and Delayed Effects of Exposure to Ionizing Radiation, New York, United Nations, 2009, pp. 1-79.
33. Kadhim M.A., Macdonald D.A., Goodhead D.T., Lorimore S.A., Marsden S.J., Wright E.G. Transmission of chromosomal instability after plutonium alpha-particle irradiation. Nature 1992, 355:738-740.
34. Bowler D.A., Moore S.R., Macdonald D.A., Smyth S.H., Clapham P., Kadhim M.A. Bystander-mediated genomic instability after high LET radiation in murine primary haemopoietic stem cells. Mutat. Res. 2006, 597:50-61.
35. Glaviano A., Mothersill C., Case C.P., Rubio M.A., Newson R., Lyng F. Effects of hTERT on genomic instability caused by either metal or radiation or combined exposure. Mutagenesis 2009, 24:25-33.
36. Rugo R.E., Almeida K.H., Hendricks C.A., Jonnalagadda V.S., Engelward B.P. A single acute exposure to a chemotherapeutic agent induces hyper-recombination in distantly descendant cells and in their neighbors. Oncogene 2005, 24:5016-5025.
37. Asur R.S., Thomas R.A., Tucker J.D. Chemical induction of the bystander effect in normal human lymphoblastoid cells. Mutat. Res. 2009, 676:11-16.
38. Demidem A., Morvan D., Madelmont J.C. Bystander effects are induced by CENU treatment and associated with altered protein secretory activity of treated tumor cells: a relay for chemotherapy?. Int. J. Cancer 2006, 119:992-1004.
39. Jin C., Wu S., Lu X., Liu Q., Qi M., Lu S., Xi Q., Cai Y. Induction of the bystander effect in Chinese hamster V79 cells by actinomycin D. Toxicol. Lett. 2011, 202:178-185.
40. Korkalainen M., Huumonen K., Naarala J., Viluksela M., Juutilainen J. Dioxin induces genomic instability in mouse embryonic fibroblasts. PLoS ONE 2012, 7:e37895.
41. Lorimore S.A., Chrystal J.A., Robinson J.I., Coates P.J., Wright E.G. Chromosomal instability in unirradiated hemaopoietic cells induced by macrophages exposed in vivo to ionizing radiation. Cancer Res. 2008, 68:8122-8126.
42. Bogdandi E.N., Balogh A., Felgyinszki N., Szatmari T., Persa E., Hildebrandt G., Safrany G., Lumniczky K. Effects of low-dose radiation on the immune system of mice after total-body irradiation. Radiat. Res. 2010, 174:480-489.
43. Buonanno M., de Toledo S.M., Pain D., Azzam E.I. Long-term consequences of radiation-induced bystander effects depend on radiation quality and dose and correlate with oxidative stress. Radiat. Res. 2011, 175:405-415.
44. Lyng F.M., Howe O.L., McClean B. Reactive oxygen species-induced release of signalling factors in irradiated cells triggers membrane signalling and calcium influx in bystander cells. Int. J. Radiat. Biol. 2011, 87:683-695.
45. Jain M.R., Li M., Chen W., Liu T., de Toledo S.M., Pandey B.N., Li H., Rabin B.M., Azzam E.I. In vivo space radiation-induced non-targeted responses: late effects on molecular signaling in mitochondria. Curr. Mol. Pharmacol. 2011, 4:106-114.
46. Kadhim M.A., Moore S.R., Goodwin E.H. Interrelationships amongst radiation-induced genomic instability, bystander effects, and the adaptive response. Mutat. Res. 2004, 568:21-32.
47. Stoler D.L., Chen N., Basik M., Kahlenberg M.S., Rodriguez-Bigas M.A., Petrelli N.J., Anderson G.R. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:15121-15126.
48. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instabilities in human cancers. Nature 1998, 396:643-649.
49. Nikiforov Y.E., Nikiforova M., Fagin J.A. Prevalence of minisatellite and microsatellite instability in radiation-induced post-Chernobyl pediatric thyroid carcinomas. Oncogene 1998, 17:1983-1988.
50. Richter H.E., Lohrer H.D., Hieber L., Kellerer A.M., Lengfelder E., Bauchinger M. Microsatellite instability and loss of heterozygosity in radiation-associated thyroid carcinomas of Belarussian children and adults. Carcinogenesis 1999, 20:2247-2252.
51. Haines J., Bacher J., Coster M., Huiskamp R., Meijne E., Mancuso M., Pazzaglia S., Bouffler S. Microsatellite instability in radiation-induced murine tumours; influence of tumour type and radiation quality. Int. J. Radiat. Biol. 2010, 86:555-568.
52. Piao C.Q., Hei T.K. Gene amplification and microsatellite instability induced in tumorigenic human bronchial epithelial cells by alpha particles and heavy ions. Radiat. Res. 2001, 155:263-267.
53. Selvanayagam C.S., Davis C.M., Cornforth M.N., Ullrich R.L. Latent expression of p53 mutations and radiation-induced mammary cancer. Cancer Res. 1995, 55:3310-3317.
54. Ullrich R.L., Ponnaiya B. Radiation-induced instability and its relation to radiation carcinogenesis. Int. J. Radiat. Biol. 1998, 74:747-754.
55. Little J.B. Radiation-induced genomic instability. Int. J. Radiat. Biol. 1998, 74:663-671.
56. Kovalchuk O., Baulch J.E. Epigenetic changes and nontargeted radiation effects-is there a link?. Environ. Mol. Mutagen. 2008, 49:16-25.
57. Baverstock K. Radiation-induced genomic instability: a paradigm-breaking phenomenon and its relevance to environmentally induced cancer. Mutat. Res. 2000, 454:89-109.
58. Moore S.R., Marsden S., MacDonald D., Mitchell S., Folkard M., Michael B., Goodhead D.T., Prise K.M., Kadhim M.A. Genomic instability in human lymphocytes irradiated with individual charged particles: involvement of tumor necrosis factor alpha in irradiated cells but not bystander cells. Radiat. Res. 2005, 163:183-190.
59. Natarajan M., Gibbons C.F., Mohan S., Moore S., Kadhim M.A. Oxidative stress signalling: a potential mediator of tumour necrosis factor alpha-induced genomic instability in primary vascular endothelial cells. Br. J. Radiol. 2007, 80(Spec No. 1):S13-S22.
60. Burr K.L., Robinson J.I., Rastogi S., Boylan M.T., Coates P.J., Lorimore S.A., Wright E.G. Radiation-induced delayed bystander-type effects mediated by hemopoietic cells. Radiat. Res. 2010, 173:760-768.
61. Rugo R.E., Mutamba J.T., Mohan K.N., Yee T., Chaillet J.R., Greenberger J.S., Engelward B.P. Methyltransferases mediate cell memory of a genotoxic insult. Oncogene 2011, 30:751-756.
62. Ilnytskyy Y., Kovalchuk O. Non-targeted radiation effects-an epigenetic connection. Mutat. Res. 2011, 714:113-125.
63. Landau D.A., Slack F.J. MicroRNAs in mutagenesis, genomic instability, and DNA repair. Semin. Oncol. 2011, 38:743-751.
64. Trott K.R., Jamali M., Manti L., Teibe A. Manifestations and mechanisms of radiation-induced genomic instability in V-79 Chinese hamster cells. Int. J. Radiat. Biol. 1998, 74:787-791.
65. Prise K.M. New advances in radiation biology. Occup. Med. (Lond.) 2006, 56:156-161.
66. Lindholm C., Acheva A., Salomaa S. Clastogenic plasma factors: a short overview. Radiat. Environ. Biophys. 2010, 49:133-138.
67. Watson G.E., Pocock D.A., Papworth D., Lorimore S.A., Wright E.G. In vivo chromosomal instability and transmissible aberrations in the progeny of haemopoietic stem cells induced by high- and low-LET radiations. Int. J. Radiat. Biol. 2001, 77:409-417.
68. Kadhim M.A., Lorimore S.A., Hepburn M.D., Goodhead D.T., Buckle V.J., Wright E.G. Alpha-particle-induced chromosomal instability in human bone marrow cells. Lancet 1994, 344:987-988.
69. Morgan W.F., Sowa M.B. Non-targeted bystander effects induced by ionizing radiation. Mutat. Res. 2007, 616:159-164.
70. Bouffler S.D., Blasco M.A., Cox R., Smith P.J. Telomeric sequences, radiation sensitivity and genomic instability. Int. J. Radiat. Biol. 2001, 77:995-1005.
71. Whitehouse C.A., Tawn E.J. No evidence for chromosomal instability in radiation workers with in vivo exposure to plutonium. Radiat. Res. 2001, 156:467-475.
72. Dugan L.C., Bedford J.S. Are chromosomal instabilities induced by exposure of cultured normal human cells to low- or high-LET radiation?. Radiat. Res. 2003, 159:301-311.
73. Ponnaiya B., Cornforth M.N., Ullrich R.L. Radiation-induced chromosomal instability in BALB/c and C57BL/6 mice: the difference is as clear as black and white. Radiat. Res. 1997, 147:121-125.
74. Watson G.E., Lorimore S.A., Clutton S.M., Kadhim M.A., Wright E.G. Genetic factors influencing alpha-particle-induced chromosomal instability. Int. J. Radiat. Biol. 1997, 71:497-503.
75. Zyuzikov N.A., Coates P.J., Parry J.M., Lorimore S.A., Wright E.G. Lack of nontargeted effects in murine bone marrow after low-dose in vivo X irradiation. Radiat. Res. 2011, 175:322-327.
76. Dubrova Y.E. Radiation-induced transgenerational instability. Oncogene 2003, 22:7087-7093.
77. Dubrova Y.E., Nesterov V.N., Krouchinsky N.G., Ostapenko V.A., Neumann R., Neil D.L., Jeffreys A.J. Human minisatellite mutation rate after the Chernobyl accident. Nature 1996, 380:683-686.
78. Dubrova Y.E., Nesterov V.N., Krouchinsky N.G., Ostapenko V.A., Vergnaud G., Giraudeau F., Buard J., Jeffreys A.J. Further evidence for elevated human minisatellite mutation rate in Belarus eight years after the Chernobyl accident. Mutat. Res. 1997, 381:267-278.
79. Dubrova Y.E., Bersimbaev R.I., Djansugurova L.B., Tankimanova M.K., Mamyrbaeva Z.Z., Mustonen R., Lindholm C., Hulten M., Salomaa S. Nuclear weapons tests and human germline mutation rate. Science 2002, 295:1037.
80. Kodaira M., Satoh C., Hiyama K., Toyama K. Lack of effects of atomic bomb radiation on genetic instability of tandem-repetitive elements in human germ cells. Am. J. Hum. Genet. 1995, 57:1275-1283.
81. Satoh C., Takahashi N., Asakawa J., Kodaira M., Kuick R., Hanash S.M., Neel J.V. Genetic analysis of children of atomic bomb survivors. Environ. Health Perspect. 1996, 104(Suppl. 3):511-519.
82. Kodaira M., Izumi S., Takahashi N., Nakamura N. No evidence of radiation effect on mutation rates at hypervariable minisatellite loci in the germ cells of atomic bomb survivors. Radiat. Res. 2004, 162:350-356.
83. Kodaira M., Ryo H., Kamada N., Furukawa K., Takahashi N., Nakajima H., Nomura T., Nakamura N. No evidence of increased mutation rates at microsatellite loci in offspring of A-bomb survivors. Radiat. Res. 2010, 173:205-213.
84. Kiuru A., Auvinen A., Luokkamaki M., Makkonen K., Veidebaum T., Tekkel M., Rahu M., Hakulinen T., Servomaa K., Rytomaa T., Mustonen R. Hereditary minisatellite mutations among the offspring of Estonian Chernobyl cleanup workers. Radiat. Res. 2003, 159:651-655.
85. Slebos R.J., Little R.E., Umbach D.M., Antipkin Y., Zadaorozhnaja T.D., Mendel N.A., Sommer C.A., Conway K., Parrish E., Gulino S., Taylor J.A. Mini-and microsatellite mutations in children from Chernobyl accident cleanup workers. Mutat. Res. 2004, 559:143-151.
86. Furitsu K., Ryo H., Yeliseeva K.G., Thuy le T.T., Kawabata H., Krupnova E.V., Trusova V.D., Rzheutsky V.A., Nakajima H., Kartel N., Nomura T. Microsatellite mutations show no increases in the children of the Chernobyl liquidators. Mutat. Res. 2005, 581:69-82.
87. Livshits L.A., Malyarchuk S.G., Kravchenko S.A., Matsuka G.H., Lukyanova E.M., Antipkin Y.G., Arabskaya L.P., Petit E., Giraudeau F., Gourmelon P., Vergnaud G., Le G.B. Children of chernobyl cleanup workers do not show elevated rates of mutations in minisatellite alleles. Radiat. Res. 2001, 155:74-80.
88. Barber R., Plumb M.A., Boulton E., Roux I., Dubrova Y.E. Elevated mutation rates in the germ line of first- and second-generation offspring of irradiated male mice. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:6877-6882.
89. Barber R.C., Hickenbotham P., Hatch T., Kelly D., Topchiy N., Almeida G.M., Jones G.D., Johnson G.E., Parry J.M., Rothkamm K., Dubrova Y.E. Radiation-induced transgenerational alterations in genome stability and DNA damage. Oncogene 2006, 25:7336-7342.
90. Hatch T., Derijck A.A., Black P.D., van der Heijden G.W., de B.P., Dubrova Y.E. Maternal effects of the scid mutation on radiation-induced transgenerational instability in mice. Oncogene 2007, 26:4720-4724.
91. Barber R.C., Hardwick R.J., Shanks M.E., Glen C.D., Mughal S.K., Voutounou M., Dubrova Y.E. The effects of in utero irradiation on mutation induction and transgenerational instability in mice. Mutat. Res. 2009, 664:6-12.
92. Vorobtsova I.E. Irradiation of male rats increases the chromosomal sensitivity of progeny to genotoxic agents. Mutagenesis 2000, 15:33-38.
93. Shiraishi K., Shimura T., Taga M., Uematsu N., Gondo Y., Ohtaki M., Kominami R., Niwa O. Persistent induction of somatic reversions of the pink-eyed unstable mutation in F1 mice born to fathers irradiated at the spermatozoa stage. Radiat. Res. 2002, 157:661-667.
94. Frankenberg-Schwager M. Induction, repair and biological relevance of radiation-induced DNA lesions in eukaryotic cells, Radiat. Environ. Biophys. 1990, 29:273-292.
95. Limoli C.L., Kaplan M.I., Phillips J.W., Adair G.M., Morgan W.F. Differential induction of chromosomal instability by DNA strand-breaking agents. Cancer Res. 1997, 57:4048-4056.
96. Dubrova Y.E., Hickenbotham P., Glen C.D., Monger K., Wong H.P., Barber R.C. Paternal exposure to ethylnitrosourea results in transgenerational genomic instability in mice. Environ. Mol. Mutagen. 2008, 49:308-311.
97. Glen C.D., Dubrova Y.E. Exposure to anticancer drugs can result in transgenerational genomic instability in mice. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:2984-2988.
98. Dubrova Y.E., Ploshchanskaya O.G., Kozionova O.S., Akleyev A.V. Minisatellite germline mutation rate in the Techa River population. Mutat. Res. 2006, 602:74-82.
99. Abouzeid Ali H.E., Barber R.C., Dubrova Y.E. The effects of maternal irradiation during adulthood on mutation induction and transgenerational instability in mice. Mutat. Res. 2012, 732:21-25.
100. Loeb L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 1991, 51:3075-3079.
101. Loeb L.A. A mutator phenotype in cancer. Cancer Res. 2001, 61:3230-3239.
102. Little J.B. Radiation carcinogenesis. Carcinogenesis 2000, 21:397-404.
103. Little J.B. Genomic instability and radiation. J. Radiol. Prot. 2003, 23:173-181.
104. Li Y., Benezra R. Identification of a human mitotic checkpoint gene: hsMAD2. Science 1996, 274:246-248.
105. Cahill D.P., Lengauer C., Yu J., Riggins G.J., Willson J.K., Markowitz S.D., Kinzler K.W., Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature 1998, 392:300-303.
106. Milner J., Ponder B., Hughes-Davies L., Seltmann M., Kouzarides T. Transcriptional activation functions in BRCA2. Nature 1997, 386:772-773.
107. Yarden R.I., Pardo-Reoyo S., Sgagias M., Cowan K.H., Brody L.C. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Genet. 2002, 30:285-289.
108. Rajagopalan H., Jallepalli P.V., Rago C., Velculescu V.E., Kinzler K.W., Vogelstein B., Lengauer C. Inactivation of hCDC4 can cause chromosomal instability. Nature 2004, 428:77-81.
109. Komarova N.L., Sengupta A., Nowak M.A. Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability. J. Theor. Biol. 2003, 223:433-450.
110. Michor F., Iwasa Y., Rajagopalan H., Lengauer C., Nowak M.A. Linear model of colon cancer initiation. Cell Cycle 2004, 3:358-362.
111. Nowak M.A., Komarova N.L., Sengupta A., Jallepalli P.V., Shih I., Vogelstein B., Lengauer C. The role of chromosomal instability in tumor initiation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:16226-16231.
112. Little M.P., Wright E.G. A stochastic carcinogenesis model incorporating genomic instability fitted to colon cancer data. Math. Biosci. 2003, 183:111-134.
113. Little M.P., Li G. Stochastic modelling of colon cancer: is there a role for genomic instability?. Carcinogenesis 2007, 28:479-487.
114. Little M.P., Vineis P., Li G. A stochastic carcinogenesis model incorporating multiple types of genomic instability fitted to colon cancer data. J. Theor. Biol. 2008, 254:229-238.
115. Tomlinson I., Bodmer W. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nat. Med. 1999, 5:11-12.
116. Luebeck E.G., Moolgavkar S.H. Multistage carcinogenesis and the incidence of colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15095-15100.
117. Bonassi S., Norppa H., Ceppi M., Stromberg U., Vermeulen R., Znaor A., Cebulska-Wasilewska A., Fabianova E., Fucic A., Gundy S., Hansteen I.L., Knudsen L.E., Lazutka J., Rossner P., Sram R.J., Boffetta P. Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries. Carcinogenesis 2008, 29:1178-1183.
118. Okayasu R., Suetomi K., Yu Y., Silver A., Bedford J.S., Cox R., Ullrich R.L. A deficiency in DNA repair and DNA-PKcs expression in the radiosensitive BALB/c mouse. Cancer Res. 2000, 60:4342-4345.
119. Coates P.J., Rundle J.K., Lorimore S.A., Wright E.G. Indirect macrophage responses to ionizing radiation: implications for genotype-dependent bystander signaling. Cancer Res. 2008, 68:450-456.
120. Boyd M., Mairs R.J., Keith W.N., Ross S.C., Welsh P., Akabani G., Owens J., Vaidyanathan G., Carruthers R., Dorrens J., Zalutsky M.R. An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects. J. Gene Med. 2004, 6:937-947.
121. Butterworth K.T., McGarry C.K., Trainor C., O'Sullivan J.M., Hounsell A.R., Prise K.M. Out-of-field cell survival following exposure to intensity-modulated radiation fields. Int. J. Radiat. Oncol. Biol. Phys. 2011, 79:1516-1522.
122. Boyd M., Ross S.C., Dorrens J., Fullerton N.E., Tan K.W., Zalutsky M.R., Mairs R.J. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides. J. Nucl. Med. 2006, 47:1007-1015.
123. Mothersill C., Seymour C. Radiation-induced bystander effects: evidence for an adaptive response to low dose exposures?. Dose Response 2006, 4:283-290.
124. Hei T.K., Zhou H., Ivanov V.N., Hong M., Lieberman H.B., Brenner D.J., Amundson S.A., Geard C.R. Mechanism of radiation-induced bystander effects: a unifying model. J. Pharm. Pharmacol. 2008, 60:943-950.
125. Blyth B.J., Sykes P.J. Radiation-induced bystander effects: what are they, and how relevant are they to human radiation exposures?. Radiat. Res. 2011, 176:139-157.
126. Camphausen K., Moses M.A., Menard C., Sproull M., Beecken W.D., Folkman J., O'Reilly M.S. Radiation abscopal antitumor effect is mediated through p53. Cancer Res. 2003, 63:1990-1993.
127. Shao C., Folkard M., Prise K.M. Role of TGF-beta1 and nitric oxide in the bystander response of irradiated glioma cells. Oncogene 2008, 27:434-440.
128. Dieriks B., De Vos W.H., Derradji H., Baatout S., Van O.P. Medium-mediated DNA repair response after ionizing radiation is correlated with the increase of specific cytokines in human fibroblasts. Mutat. Res. 2010, 687:40-48.
129. Gow M.D., Seymour C.B., Ryan L.A., Mothersill C.E. Induction of bystander response in human glioma cells using high-energy electrons: a role for TGF-beta1. Radiat. Res. 2010, 173:769-778.
130. Rodel F., Frey B., Capalbo G., Gaipl U., Keilholz L., Voll R., Hildebrandt G., Rodel C. Discontinuous induction of X-linked inhibitor of apoptosis in EA.hy.926 endothelial cells is linked to NF-kappaB activation and mediates the anti-inflammatory properties of low-dose ionising-radiation. Radiother. Oncol. 2010, 97:346-351.
131. Burdak-Rothkamm S., Short S.C., Folkard M., Rothkamm K., Prise K.M. ATR-dependent radiation-induced gamma H2AX foci in bystander primary human astrocytes and glioma cells. Oncogene 2007, 26:993-1002.
132. Chapman K.L., Kelly J.W., Lee R., Goodwin E.H., Kadhim M.A. Tracking genomic instability within irradiated and bystander populations. J. Pharm. Pharmacol. 2008, 60:959-968.
133. Belyakov O.V., Malcolmson A.M., Folkard M., Prise K.M., Michael B.D. Direct evidence for a bystander effect of ionizing radiation in primary human fibroblasts. Br. J. Cancer 2001, 84:674-679.
134. Little M.P., Filipe J.A., Prise K.M., Folkard M., Belyakov O.V. A model for radiation-induced bystander effects, with allowance for spatial position and the effects of cell turnover. J. Theor. Biol. 2005, 232:329-338.
135. Schettino G., Folkard M., Michael B.D., Prise K.M. Low-dose binary behavior of bystander cell killing after microbeam irradiation of a single cell with focused c(k) X-rays. Radiat. Res. 2005, 163:332-336.
136. Mancuso M., Pasquali E., Leonardi S., Tanori M., Rebessi S., di M., Pazzaglia V.S., Toni M.P., Pimpinella M., Covelli V., Saran A. Oncogenic bystander radiation effects in patched heterozygous mouse cerebellum. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:12445-12450.
137. Sham R.L. The abscopal effect and chronic lymphocytic leukemia. Am. J. Med. 1995, 98:307-308.
138. Mothersill C., Seymour C. Medium from irradiated human epithelial cells but not human fibroblasts reduces the clonogenic survival of unirradiated cells. Int. J. Radiat. Biol. 1997, 71:421-427.
139. Nagar S., Smith L.E., Morgan W.F. Mechanisms of cell death associated with death-inducing factors from genomically unstable cell lines. Mutagenesis 2003, 18:549-560.
140. Hagelstrom R.T., Askin K.F., Williams A.J., Ramaiah L., Desaintes C., Goodwin E.H., Ullrich R.L., Bailey S.M. DNA-PKcs and ATM influence generation of ionizing radiation-induced bystander signals. Oncogene 2008, 27:6761-6769.
141. Kadhim M.A., Lee R., Moore S.R., Macdonald D.A., Chapman K.L., Patel G., Prise K.M. Genomic instability after targeted irradiation of human lymphocytes: evidence for inter-individual differences under bystander conditions. Mutat. Res. 2010, 688:91-94.
142. Lyng F.M., Seymour C.B., Mothersill C. Production of a signal by irradiated cells which leads to a response in unirradiated cells characteristic of initiation of apoptosis. Br. J. Cancer 2000, 83:1223-1230.
143. Kashino G., Prise K.M., Suzuki K., Matsuda N., Kodama S., Suzuki M., Nagata K., Kinashi Y., Masunaga S., Ono K., Watanabe M. Effective suppression of bystander effects by DMSO treatment of irradiated CHO cells. J. Radiat. Res. 2007, 48:327-333.
144. Shao C., Lyng F.M., Folkard M., Prise K.M. Calcium fluxes modulate the radiation-induced bystander responses in targeted glioma and fibroblast cells. Radiat. Res. 2006, 166:479-487.
145. Banaz-Yasar F., Lennartz K., Winterhager E., Gellhaus A. Radiation-induced bystander effects in malignant trophoblast cells are independent from gap junctional communication. J. Cell Biochem. 2008, 103:149-161.
146. Azzam E.I., de Toledo S.M., Gooding T., Little J.B. Intercellular communication is involved in the bystander regulation of gene expression in human cells exposed to very low fluences of alpha particles. Radiat. Res. 1998, 150:497-504.
147. Azzam E.I., de Toledo S.M., Little J.B. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to nonirradiated cells. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:473-478.
148. Lehnert B.E., Goodwin E.H., Deshpande A. Extracellular factor(s) following exposure to alpha particles can cause sister chromatid exchanges in normal human cells. Cancer Res. 1997, 57:2164-2171.
149. Mothersill C., Seymour C.B. Cell-cell contact during gamma irradiation is not required to induce a bystander effect in normal human keratinocytes: evidence for release during irradiation of a signal controlling survival into the medium. Radiat. Res. 1998, 149:256-262.
150. Ghandhi S.A., Yaghoubian B., Amundson S.A. Global gene expression analyses of bystander and alpha particle irradiated normal human lung fibroblasts: synchronous and differential responses. BMC Med. Genomics 2008, 1:63.
151. Vines A.M., Lyng F.M., McClean B., Seymour C., Mothersill C.E. Bystander effect induced changes in apoptosis related proteins and terminal differentiation in in vitro murine bladder cultures. Int. J. Radiat. Biol. 2009, 85:48-56.
152. Belyakov O.V., Folkard M., Mothersill C., Prise K.M., Michael B.D. Bystander-induced differentiation: a major response to targeted irradiation of a urothelial explant model. Mutat. Res. 2006, 597:43-49.
153. Lorimore S.A., Coates P.J., Wright E.G. Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation. Oncogene 2003, 22:7058-7069.
154. Calabrese E.J., Baldwin L.A. Hormesis: a generalizable and unifying hypothesis. Crit. Rev. Toxicol. 2001, 31:353-424.
155. Klammer H., Kadhim M., Iliakis G. Evidence of an adaptive response targeting DNA nonhomologous end joining and its transmission to bystander cells. Cancer Res. 2010, 70:8498-8506.
156. Pinto M., Azzam E.I., Howell R.W. Investigation of adaptive responses in bystander cells in 3D cultures containing tritium-labeled and unlabeled normal human fibroblasts. Radiat. Res. 2010, 174:216-227.
157. Ullrich R.L. Tumor induction in BALB/c mice after fractionated or protracted exposures to fission-spectrum neutrons. Radiat. Res. 1984, 97:587-597.
158. Maisin J.R., Wambersie A., Gerber G.B., Mattelin G., Lambiet-Collier M., Gueulette J. The effects of a fractionated gamma irradiation on life shortening and disease incidence in BALB/c mice. Radiat. Res. 1983, 94:359-373.
159. Maisin J.R., Wambersie A., Gerber G.B., Mattelin G., Lambiet-Collier M., De C.B., Gueulette J. Life-shortening and disease incidence in C57Bl mice after single and fractionated gamma and high-energy neutron exposure. Radiat. Res. 1988, 113:300-317.
160. Maisin J.R., Wambersie A., Gerber G.B., Mattelin G., Lambiet-Collier M., De C.B., Gueulette J. Life-shortening and disease incidence in mice after exposure to gamma rays or high-energy neutrons. Radiat. Res. 1991, 128:S117-S123.
161. Shadley J.D., Wiencke J.K. Induction of the adaptive response by X-rays is dependent on radiation intensity. Int. J. Radiat. Biol. 1989, 56:107-118.
162. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), Sources and effects of ionizing radiation, UNSCEAR 1994 report to the General Assembly, with scientific annexes, E.94.IX.11, New York, United Nations, 1994, pp. 1-272.
163. Joiner M.C., Lambin P., Malaise E.P., Robson T., Arrand J.E., Skov K.A., Marples B. Hypersensitivity to very-low single radiation doses: its relationship to the adaptive response and induced radioresistance. Mutat. Res. 1996, 358:171-183.
164. Joiner M.C., Marples B., Lambin P., Short S.C., Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. Int. J. Radiat. Oncol. Biol. Phys. 2001, 49:379-389.
165. National Council on Radiation Protection and Measurements (NCRP), Report No. 136, Evaluation of the linear-nonthreshold dose-response model for ionizing radiation, 2001, 1-287.
166. Brenner D.J., Doll R., Goodhead D.T., Hall E.J., Land C.E., Little J.B., Lubin J.H., Preston D.L., Preston R.J., Puskin J.S., Ron E., Sachs R.K., Samet J.M., Setlow R.B., Zaider M. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:13761-13766.
167. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), UNSCEAR 2006 Report, Annex A, Epidemiological Studies of Radiation and Cancer, New York, United Nations, 2008, pp. 13-322.
168. International Commission on Radiological Protection, Low-dose extrapolation of radiation-related cancer risk, Ann. ICRP 35 (2005) 1-140.
169. Brenner D.J., Little J.B., Sachs R.K. The bystander effect in radiation oncogenesis: II. A quantitative model. Radiat. Res. 2001, 155:402-408.
170. Little M.P., Wakeford R. The bystander effect in C3H 10T1/2 cells and radon-induced lung cancer. Radiat. Res. 2001, 156:695-699.
171. Limoli C.L., Corcoran J.J., Jordan R., Morgan W.F., Schwartz J.L. A role for chromosomal instability in the development of and selection for radioresistant cell variants. Br. J. Cancer 2001, 84:489-492.
172. Belyakov O.V., Folkard M., Mothersill C., Prise K.M., Michael B.D. A proliferation-dependent bystander effect in primary porcine and human urothelial explants in response to targeted irradiation. Br. J. Cancer 2003, 88:767-774.
173. Mothersill C., Smith R.W., Agnihotri N., Seymour C.B. Characterization of a radiation-induced stress response communicated in vivo between zebrafish. Environ. Sci. Technol. 2007, 41:3382-3387.
174. Doll R., Wakeford R. Risk of childhood cancer from fetal irradiation. Br. J. Radiol. 1997, 70:130-139.
175. Harvey E.B., Boice J.D., Honeyman M., Flannery J.T. Prenatal X-ray exposure and childhood cancer in twins. N. Engl. J. Med. 1985, 312:541-545.
176. MacMahon B. Prenatal X-ray exposure and childhood cancer. J. Natl. Cancer Inst. 1962, 28:1173-1191.
177. Wakeford R., Little M.P. Risk coefficients for childhood cancer after intrauterine irradiation: a review. Int. J. Radiat. Biol. 2003, 79:293-309.
178. Stewart A., Webb J., Hewitt D. A survey of childhood malignancies. Br. Med. J. 1958, 1:1495-1508.
179. International Commission on Radiological Protection, Biological effects after prenatal irradiation (embryo and fetus), A report of the International Commission on Radiological Protection, Ann. ICRP 33 (2003) 5-206.
180. Preston D.L., Cullings H., Suyama A., Funamoto S., Nishi N., Soda M., Mabuchi K., Kodama K., Kasagi F., Shore R.E. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J. Natl. Cancer Inst. 2008, 100:428-436.
181. Pearce M.S., Salotti J.A., Little M.P., McHugh K., Lee C., Kim K.P., Howe N.L., Ronckers C.M., Rajaraman P., Sir Craft A.W., Parker L., Berrington de G.A. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012, 380:499-505.
182. Kendall G.M., Little M.P., Wakeford R., Bunch K.J., Miles J.C., Vincent T.J., Meara J.R., Murphy M.F. A record-based case-control study of natural background radiation and the incidence of childhood leukaemia and other cancers in Great Britain during 1980-2006. Leukemia 2012, [Epub ahead of print]. 10.1038/leu.2012.151.
183. Adams M.J., Hardenbergh P.H., Constine L.S., Lipshultz S.E. Radiation-associated cardiovascular disease. Crit. Rev. Oncol. Hematol. 2003, 45:55-75.
184. Schultz-Hector S., Trott K.R. Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?. Int. J. Radiat. Oncol. Biol. Phys. 2007, 67:10-18.
185. Shimizu Y., Kodama K., Nishi N., Kasagi F., Suyama A., Soda M., Grant E.J., Sugiyama H., Sakata R., Moriwaki H., Hayashi M., Konda M., Shore R.E. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ 2010, 340:b5349.
186. Yamada M., Wong F.L., Fujiwara S., Akahoshi M., Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat. Res. 2004, 161:622-632.
187. Howe G.R., Zablotska L.B., Fix J.J., Egel J., Buchanan J. Analysis of the mortality experience amongst U.S. nuclear power industry workers after chronic low-dose exposure to ionizing radiation. Radiat. Res. 2004, 162:517-526.
188. Ivanov V.K., Maksioutov M.A., Chekin S.Y., Petrov A.V., Biryukov A.P., Kruglova Z.G., Matyash V.A., Tsyb A.F., Manton K.G., Kravchenko J.S. The risk of radiation-induced cerebrovascular disease in Chernobyl emergency workers. Health Phys. 2006, 90:199-207.
189. McGeoghegan D., Binks K., Gillies M., Jones S., Whaley S. The non-cancer mortality experience of male workers at British Nuclear Fuels plc, 1946-2005. Int. J. Epidemiol. 2008, 37:506-518.
190. Muirhead C.R., O'Hagan J.A., Haylock R.G., Phillipson M.A., Willcock T., Berridge G.L., Zhang W. Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers. Br. J. Cancer 2009, 100:206-212.
191. Laurent O., Metz-Flamant C., Rogel A., Hubert D., Riedel A., Garcier Y., Laurier D. Relationship between occupational exposure to ionizing radiation and mortality at the French electricity company, period 1961-2003. Int. Arch. Occup. Environ. Health 2010, 83:935-944.
192. Azizova T.V., Muirhead C.R., Druzhinina M.B., Grigoryeva E.S., Vlasenko E.V., Sumina M.V., O'Hagan J.A., Zhang W., Haylock R.G., Hunter N. Cardiovascular diseases in the cohort of workers first employed at Mayak PA in 1948-1958. Radiat. Res. 2010, 174:155-168.
193. Azizova T.V., Muirhead C.R., Druzhinina M.B., Grigoryeva E.S., Vlasenko E.V., Sumina M.V., O'Hagan J.A., Zhang W., Haylock R.G., Hunter N. Cerebrovascular diseases in the cohort of workers first employed at Mayak PA in 1948-1958. Radiat. Res. 2010, 174:851-864.
194. Vrijheid M., Cardis E., Ashmore P., Auvinen A., Bae J.M., Engels H., Gilbert E., Gulis G., Habib R., Howe G., Kurtinaitis J., Malker H., Muirhead C., Richardson D., Rodriguez-Artalejo F., Rogel A., Schubauer-Berigan M., Tardy H., Telle-Lamberton M., Usel M., Veress K. Mortality from diseases other than cancer following low doses of ionizing radiation: results from the 15-Country Study of nuclear industry workers. Int. J. Epidemiol. 2007, 36:1126-1135.
195. Clarke M.C., Littlewood T.D., Figg N., Maguire J.J., Davenport A.P., Goddard M., Bennett M.R. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ. Res. 2008, 102:1529-1538.
196. Kavurma M.M., Figg N., Bennett M.R., Mercer J., Khachigian L.M., Littlewood T.D. Oxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitment. Biochem. J. 2007, 407:79-87.
197. Schwartz S.M., Murry C.E. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu. Rev. Med. 1998, 49:437-460.
198. Little M.P. Do non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model?. Mutat. Res. 2010, 687:17-27.
199. Hayashi T., Morishita Y., Kubo Y., Kusunoki Y., Hayashi I., Kasagi F., Hakoda M., Kyoizumi S., Nakachi K. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors. Am. J. Med. 2005, 118:83-86.
200. Hayashi T., Kusunoki Y., Hakoda M., Morishita Y., Kubo Y., Maki M., Kasagi F., Kodama K., MacPhee D.G., Kyoizumi S. Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors. Int. J. Radiat. Biol. 2003, 79:129-136.
201. Ridker P.M. Inflammation, infection, and cardiovascular risk: how good is the clinical evidence?. Circulation 1998, 97:1671-1674.
202. Gura T. Infections: a cause of artery-clogging plaques?. Science 1998, 281. 35, 37.
203. Kusunoki Y., Kyoizumi S., Hirai Y., Suzuki T., Nakashima E., Kodama K., Seyama T. Flow cytometry measurements of subsets of T, B and NK cells in peripheral blood lymphocytes of atomic bomb survivors. Radiat. Res. 1998, 150:227-236.
204. Kusunoki Y., Kyoizumi S., Yamaoka M., Kasagi F., Kodama K., Seyama T. Decreased proportion of CD4 T cells in the blood of atomic bomb survivors with myocardial infarction. Radiat. Res. 1999, 152:539-543.
205. Stewart F.A., Heeneman S., Te P.J., Kruse J., Russell N.S., Gijbels M., Daemen M. Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am. J. Pathol. 2006, 168:649-658.
206. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
207. Little M.P., Gola A., Tzoulaki I. A model of cardiovascular disease giving a plausible mechanism for the effect of fractionated low-dose ionizing radiation exposure. PLoS Comput. Biol. 2009, 5:e1000539.
208. Minamoto A., Taniguchi H., Yoshitani N., Mukai S., Yokoyama T., Kumagami T., Tsuda Y., Mishima H.K., Amemiya T., Nakashima E., Neriishi K., Hida A., Fujiwara S., Suzuki G., Akahoshi M. Cataract in atomic bomb survivors. Int. J. Radiat. Biol. 2004, 80:339-345.
209. Nakashima E., Neriishi K., Minamoto A. A reanalysis of atomic-bomb cataract data, 2000-2002: a threshold analysis. Health Phys. 2006, 90:154-160.
210. Neriishi K., Nakashima E., Akahoshi M., Hida A., Grant E.J., Masunari N., Funamoto S., Minamoto A., Fujiwara S., Shore R.E. Radiation dose and cataract surgery incidence in atomic bomb survivors, 1986-2005. Radiology 2012, 265:167-174.
211. Chylack L.T., Peterson L.E., Feiveson A.H., Wear M.L., Manuel F.K., Tung W.H., Hardy D.S., Marak L.J., Cucinotta F.A. NASA study of cataract in astronauts (NASCA). Report 1: cross-sectional study of the relationship of exposure to space radiation and risk of lens opacity. Radiat. Res. 2009, 172:10-20.
212. Blakely E.A., Kleiman N.J., Neriishi K., Chodick G., Chylack L.T., Cucinotta F.A., Minamoto A., Nakashima E., Kumagami T., Kitaoka T., Kanamoto T., Kiuchi Y., Chang P., Fujii N., Shore R.E. Radiation cataractogenesis: epidemiology and biology. Radiat. Res. 2010, 173:709-717.
213. Di P.M., Coppola M., Baarli T., Bianchi M., Sullivan A.H. Biological responses to various neutron energies from 1 to 600MeV. A II. Lens opacification in mice. Radiat. Res. 1980, 84:453-461.
214. Preston D.L., Shimizu Y., Pierce D.A., Suyama A., Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950-1997. Radiat. Res. 2003, 160:381-407.
215. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), UNSCEAR 2006 Report, Annex B, Epidemiological Evaluation of Cardiovascular Disease and other Non-Cancer Diseases following Radiation Exposure, New York, United Nations, 2008, pp. 325-383.
216. Syndikus I., Tait D., Ashley S., Jannoun L. Long-term follow-up of young children with brain tumors after irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1994, 30:781-787.
217. Hall P., Adami H.O., Trichopoulos D., Pedersen N.L., Lagiou P., Ekbom A., Ingvar M., Lundell M., Granath F. Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study. BMJ 2004, 328:19.
218. Schull W.J., Otake M. Cognitive function and prenatal exposure to ionizing radiation. Teratology 1999, 59:222-226.
219. Little M.P. Cancer and non-cancer effects in Japanese atomic bomb survivors. J. Radiol. Prot. 2009, 29:A43-A59.
220. Pearce M.S., Salotti J.A., Little M.P., McHugh K., Lee C., Kim K.P., Howe N.L., Ronckers C.M., Rajaraman P., Craft A.W., Parker L., de A.B., Gonzalez Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012, 380:499-505.
221. Nowak M.A., Komarova N.L., Sengupta A., Jallepalli P.V., Shih I.M., Vogelstein B., Lengauer C. The role of chromosomal instability in tumor initiation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:16226-16231.
222. Brenner D.J., Sachs R.K. Do low dose-rate bystander effects influence domestic radon risks?. Int. J. Radiat. Biol. 2002, 78:593-604.
223. Little M.P. The bystander effect model of Brenner and Sachs fitted to lung cancer data in 11 cohorts of underground miners, and equivalence of fit of a linear relative risk model with adjustment for attained age and age at exposure. J. Radiol. Prot. 2004, 24:243-255.
224. Nikjoo H., Khvostunov I.K. Biophysical model of the radiation-induced bystander effect. Int. J. Radiat. Biol. 2003, 79:43-52.
225. Stewart R.D., Ratnayake R.K., Jennings K. Microdosimetric model for the induction of cell killing through medium-borne signals. Radiat. Res. 2006, 165:460-469.
226. Hall P., Granath F., Lundell M., Olsson K., Holm L.E. Lenticular opacities in individuals exposed to ionizing radiation in infancy. Radiat. Res. 1999, 152:190-195.
227. Rafnsson V., Olafsdottir E., Hrafnkelsson J., Sasaki H., Arnarsson A., Jonasson F. Cosmic radiation increases the risk of nuclear cataract in airline pilots: a population-based case-control study. Arch. Ophthalmol. 2005, 123:1102-1105.
228. Chodick G., Bekiroglu N., Hauptmann M., Alexander B.H., Freedman D.M., Doody M.M., Cheung L.C., Simon S.L., Weinstock R.M., Bouville A., Sigurdson A.J. Risk of cataract after exposure to low doses of ionizing radiation: a 20-year prospective cohort study among US radiologic technologists. Am. J. Epidemiol. 2008, 168:620-631.
229. Mrena S., Kivela T., Kurttio P., Auvinen A. Lens opacities among physicians occupationally exposed to ionizing radiation-a pilot study in Finland. Scand. J. Work Environ. Health 2011, 37:237-243.